opportunities for improvement. approval. Facilitate development of governance arrangements for analysis and publication of data. JBC to consider a National Blood Data and Information Governance Framework developed by the NBA by 30 June 2013. Goal 3 - Promote a best practice model of management and use of blood and blood related products and services in Australia. Strategic Priority Description of activities Responsibilities and Key milestones 3.1 Advocate management of blood and blood products in accordance with the National Stewardship Expectations for the Supply of Blood and Blood Products. Arrange for the integration of the Stewardship Statement into materials, programs and policies at a national and jurisdictional level. Raise awareness of the Stewardship Statement across public and private health care providers. Identify any barriers or perverse incentives to behaviours which underpin the Stewardship Statement. JBC to advise on opportunities for the integration of the Stewardship Statement into materials, programs and policies at a national and jurisdictional level and consider relevant proposals from NBA. Commonwealth to review MBS item for transfusion and, in consultation with relevant jurisdictions, provide advice to JBC by June 2013 3.2 Identify opportunities to support implementation of the National Safety and Quality Health Service (NSQHS) Blood Standard. Facilitate development of tools and strategies to assist Approved Health Providers (AHPs) to implement the NSQHS Blood Standard. JBC to consider NBA proposals for tools and strategies to assist AHPs to implement the Blood Standard. 3.3 Support appropriate use of blood and blood products through encouraging and promoting the integration of Patient Blood Management (PBM) programs in health care provider systems. Continue to support the development of Patient Blood Management guidelines and identify opportunities to support their dissemination and uptake. JBC to monitor the development of agreed PBM guidelines by NBA. JBC to consider NBA proposals for implementation and dissemination of the PBM guidelines Consider the elements of a proposed national PBM program and provide advice to AHMAC through the HPC. Facilitate implementation of any agreed elements. JBC to initiate agreed projects that support a national PBM program. 3.4 Ensure that nationally consistent and effective clinical governance and Provide advice to Health Ministers on the recommendations of the Review of JBC advice to SCoH on recommendations by first quarter 2013.
authorisation arrangements are in place for high cost blood products. Authorisation and Clinical Governance Framework for Intravenous Immunoglobulin (IVIg). Facilitate implementation of recommendations agreed by Health Ministers. Agreed recommendations of the review are to be implemented from early 2014 3.5 Provide advice to Health Ministers on proposed benchmarks and national performance measures for appropriate use of blood and blood products. Endorse agreed benchmarks and national performance measures on appropriate use, which leverage information already collected or available, for referral to Health Ministers. JBC to consider proposals from JBC about potential measures by December 2013. 3.6 Build and promote sharing of knowledge and identify and promote best practice in clinical governance and practice. Support the development of blood-related education materials for the health workforce and promote their national uptake and evaluation. BloodSafe e-learning Australia program is to develop a further three modules. JBC to oversight the evaluation of the effectiveness of the BloodSafe e-learning program by September 2015. JBC to provide advice to the NBA about the development of further guidelines. Monitor, and report on, implementation of the revised Criteria for Clinical Use of IVIg. NBA to publish and disseminate new Criteria. JBC to monitor IVIg usage reports and provide advice on any significant variation to estimated demand to AHPC. 3.7 Improve private sector engagement to promote a better understanding of issues, including capacity for more efficient and appropriate use, in particular Support the development of a Private Sector Engagement Framework and facilitate private sector interest. JBC to consider NBA proposals to engage private sector hospitals and laboratories as part of the implementation of the Statement on National Stewardship Expectations for the Supply of Blood and Blood Products)
within the context of the broader health system. Goal 4 - Develop policy and provide policy advice on the sustainability of the blood sector in Australia, including financial sustainability. Strategic Priority Description of activities Responsibilities and Key milestones 4.1 Ensure reliable, consistent and decision-making about risks and proposals to address these risks in the blood sector. Explore the feasibility of a national integrated risk management framework for the sector The Commonwealth to undertake a preliminary analysis of the work required to identify risk management priorities from “vein to vein” and report back to JBC. JBC to consider the policy principles to underpin systemic risk management priorities. 4.2 Provide advice on improving for money for governments under the Deed of Agreement with the Blood Service, including strategies to address risks for governments and the Blood Service. Oversee continued refinements to the Output Based Funding Model (OBFM) arrangements to get better value for money for governments. Provide direction to the NBA in negotiating any new or amended principles to underpin a new Agreement commencing 2014-15 and opportunities for improving arrangements for roll overs of the current Deed. The NBA to negotiate revised OBFM principles with the Blood Service by December 2012. NBA to advise JBC on any proposed new OBFM arrangements for 2013-14 to 2015-16 within requested timeframe. Arrange for, and participate in a review of the National Managed Fund (NMF) and statutory defence legislation. Develop advice for consideration of Health Ministers. NBA to conduct review of the NMF and statutory defence legislation to be completed by December 2013. JBC to provide the outcomes of the review and advice to SCoH by first half of 2014.
4.3 long-term policy and planning priorities, including in the broader context of health reform. Hold periodic stakeholder forums to discuss strategic blood policy matters. Blood Policy Forums and commissioned research to guide the development of a strategic policy and research agenda for the blood sector. The Blood Policy Forum Advisory Committee to organise periodic Blood Policy Forums. JBC to consider identified national research priorities developed by the NBA by June 2013 Advice and report on the feasibility of integrating blood into health reform and opportunities to strengthen the evidence base for blood use and costs. The Commonwealth working with the NBA to liaise with health reform bodies about the possible integration of blood into health reform based on sufficient evidence.